首页> 外文期刊>ACS applied materials & interfaces >Stimulus-Responsive, Biodegradable, Biocompatible, Covalently Cross-Linked Hydrogel Based on Dextrin and Poly(N-isopropylacrylamide) for in Vitro/in Vivo Controlled Drug Release
【24h】

Stimulus-Responsive, Biodegradable, Biocompatible, Covalently Cross-Linked Hydrogel Based on Dextrin and Poly(N-isopropylacrylamide) for in Vitro/in Vivo Controlled Drug Release

机译:基于糊精和聚(N-异丙基丙烯酰胺)的刺激响应性,可生物降解,生物相容性,共价交联的水凝胶用于体内/体外控制药物释放

获取原文
获取原文并翻译 | 示例
       

摘要

A novel stimulus-sensitive covalently cross-linked hydrogel derived from dextrin, N-isopropylacrylamide, and N,N'-methylene bis(acrylamide) (c-Dxt/pNIPAm), has been synthesized via Michael type addition reaction for controlled drug release application. The chemical structure of c-Dxt/pNIPAm has been confirmed through Fourier transform infrared (FTIR) spectroscopy and H-1 and C-13 NMR spectral analyses. The surface morphology of the hydrogel has been studied by field emission scanning electron microscopic (FE-SEM) and environmental scanning electron microscopic (E-SEM) analyses. The stimulus responsiveness of the hydrogel was studied through equilibrium swelling in various pH media at 25 and 37 degrees C. Rheological study was performed to measure the gel strength and gelation time. Noncytotoxicity of c-Dxt/pNIPAm hydrogel has been studied using human mesenchymal stem cells (hMSCs). The biodegradability of c-Dxt/pNIPAm was confirmed using hen egg lysozyme. The in vitro and in vivo release studies of ornidazole and ciprofloxacin imply that c-Dxt/pNIPAm delivers both drugs in a controlled way and would be an excellent alternative for a dual drug carrier. The FTIR, powder X-ray diffraction (XRD), and UV vis near infrared (NIR) spectra along with the computational study predict that the drugs remain in the matrix through physical interaction. A stability study signifies that the drugs (ornidazole similar to 97% and ciprofloxacin similar to 98%) are stable in the tablet formulations for up to 3 months.
机译:通过糊精,N-异丙基丙烯酰胺和N,N'-亚甲基双(丙烯酰胺)(c-Dxt / pNIPAm)衍生的新型刺激敏感的共价交联水凝胶已通过迈克尔型加成反应合成,用于药物的控制释放。 c-Dxt / pNIPAm的化学结构已通过傅立叶变换红外(FTIR)光谱以及H-1和C-13 NMR光谱分析得到了证实。通过场发射扫描电子显微镜(FE-SEM)和环境扫描电子显微镜(E-SEM)分析研究了水凝胶的表面形态。通过在25和37℃下在各种pH介质中平衡溶胀来研究水凝胶的刺激响应性。进行流变学研究以测量凝胶强度和胶凝时间。已经使用人间充质干细胞(hMSCs)研究了c-Dxt / pNIPAm水凝胶的非细胞毒性。使用鸡蛋溶菌酶证实了c-Dxt / pNIPAm的生物降解性。奥硝唑和环丙沙星的体外和体内释放研究表明,c-Dxt / pNIPAm以受控方式递送两种药物,将是双重药物载体的绝佳替代品。 FTIR,粉末X射线衍射(XRD)和UV-vis近红外(NIR)光谱以及计算研究预测,药物通过物理相互作用保留在基质中。稳定性研究表明,这些药物(奥硝唑(相当于97%)和环丙沙星(相当于98%))在片剂中的稳定性长达3个月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号